Manufacturer record
Mayasha Lifesciences H.B. 86: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by Mayasha Lifesciences H.B. 86 (Himachal Pradesh) were declared Not of Standard Quality between July 2025 and August 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: MDT-4635, Aceclofenac, Paracetamol & Seratiopeptidase Tablets (exp Oct 2027). LUCKNOW LAB (state lab) found it not of standard quality: The sample does not conform to declared formula, in respect of Content of Paracetamol & Aceclofenac. Listed in the August 2026 alert.
Records by type
3 records linked to Mayasha Lifesciences H.B. 86 in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Aceclofenac, Paracetamol & Seratiopeptidase Tablets | Batch MDT-4635Mfg Nov 2025 · Exp Oct 2027 | The sample does not conform to declared formula, in respect of Content of Paracetamol & AceclofenacOther | LUCKNOW LABState lab | Aug 2026 |
| Amoxyclllin CapsulesIP 250mg | Batch MBC-111Mfg Oct 2024 · Exp Sep 2026 | The sample fails to comply in respect of contains of the drug which is less than the calimOther | DTL BhopalState lab | Jul 2026 |
| Ursodeoxycholic Acid Tablets IP | Batch MDT-3717Mfg Jan 2025 · Exp Dec 2026 | Dissolution and Assay.Assay | CDTL, MumbaiCDSCO lab | Jul 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.